Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1, 2025. This article details how to bill for…
Effective July 6, 2026, outpatient claims with type of bills (TOB) 13X or 14X will be returned to provider (RTP) for reason code 34554 if modifier ER, PO, or PN is billed on all service lines, and the practice location address is missing fr…
This article will assist Medicare Part A providers with proper billing relating to COVID-19 vaccine and monoclonal antibody infusion. Beneficiary coinsurance and deductible are waived.
Medicare Part B covers various colorectal cancer (CRC) screening tests furnished to individuals for the purpose of early detection of colon cancer. Learn more about these lifesaving preventive services.